Our Partnerships and Contributions in Ireland

The UK and Ireland are world-leading hubs for Life Science innovation. Ipsen believes that an effective working relationship with the UK & Irish governments is a crucial part of this success.

We understand that building pioneering partnerships with key stakeholder groups is essential to unlock positive change for patients with rare and underserved conditions, collaborating with the government is key to improving patients’ lives through specialty care in Ireland across the country, with the pandemic being a catalyst for collaboration and enhanced trust between the pharmaceutical sector in Ireland (& internationally) and policy makers. Not only are biopharmaceutical companies working together with governments and regulatory bodies to ensure the delivery of safe vaccines, but biopharmaceutical companies have also been able to ensure the continuity of supply of vital medicines. Ipsen has been a long-term employer in the Dublin West area since it first established its Blanchardstown site in 1989. We endeavour to influence positive change among policy makers, locally in Dublin, and Ireland, to ensure the needs of patients with rare and life-threatening diseases are met. 

Through proactively engaging with the government, policymakers, and other elected representatives we strive to improve patients’ health and transform lives.

Ipsen understands that working in partnership with those around us is a cornerstone of achieving meaningful change for patients. We strive for genuine collaboration with advocacy groups, always putting patients at the heart of everything we do. We support the work of many patient advocacy groups across the UK and Ireland, working in partnership, we aim to help people and families affected by debilitating conditions to live better lives.

Improving the lives of patients is what drives us at Ipsen. We view our work with patient advocacy groups as a pivotal part of delivering on that ambition. At Ipsen we pride ourselves on working with patient advocacy groups in a way that reflects our core ethical values and maintains integrity. We strive to build long-term partnerships that offer mutual value, support the independent initiatives of patient advocacy groups and help them achieve their ambitions for patients.

Over the past couple of years, Ipsen, like many other biopharmaceutical companies, has transitioned away from supporting patient organisations primarily through the mechanism of grants & donations. As such we no longer have a designated grants & donations allocation each year. Of course, working with and supporting patient groups is still critically important for us – our mission to support better outcomes for patients is uppermost for the company. We are keen to explore projects where we can collaborate, be this through developing partnership activities or through areas like sponsorship.

If you are representing a patient organisation or charity and would like to speak to us about a potential partnership, please contact us via the Contact Us button on this website.